A

Ampersand

Modular therapeutics localized to diseased tissues

Scientist – Senior Scientist - Cell Engineering & Assay Development, Microfluidics Team

Translational Research & Bench BiologyUpdated on Nov 15
Full-timeWatertown, MA, USAIn-person

About the Job

Requirements

  • A PhD in Cell Biology, Immunology, Molecular Biology, Bioengineering, Biomedical Engineering, Biochemistry, Biophysics, or a related field; or an MS with substantial relevant industry experience.
  • Demonstrated hands-on experience designing reporter constructs and engineering and qualifying stable mammalian reporter cell lines for pathway-responsive functional assays.
  • Hands-on experience in mammalian vector design and stable multi-gene cell-line engineering, including genomic integration and functional validation.
  • Strong hands-on experience with mammalian cell culture, cell handling, transfection workflows, cell selection, and cell-based assay execution.
  • Demonstrated experience leading the development and optimization of biological assays, preferably protein-based, cell-based, or high-throughput screening assays.
  • Experience with fluorescence-based detection platforms such as flow cytometry, fluorescence-activated cell sorting (FACS), microscopy, plate readers, or related systems.
  • Experience with antibody engineering, antibody discovery, directed evolution, display technologies, recombinant protein library screening, or pooled cell-library workflows.
  • Ability to design experiments, troubleshoot complex biological systems, interpret quantitative data, and make clear recommendations based on results.
  • Excellent written and verbal communication skills, with the ability to work effectively across biology, molecular biology, engineering, and platform teams.
  • Enthusiasm for working in a fast-paced, early-stage biotech environment, including regular collaboration with colleagues across United States and European time zones.

Responsibilities

  • Collaborate with molecular biology scientists to define library-cell vector designs, expression formats, transfection strategies, cell selection approaches, and assay-readiness criteria.
  • Establish workflows for transfecting, expanding, selecting, and qualifying library cell populations for downstream screening.
  • Independently design, build, and qualify stable mammalian cells with controlled co-expression of a signaling receptor, an additional cell-surface target, and a pathway-responsive fluorescent reporter.
  • Lead the development and optimization of biochemical and cell-based droplet-compatible assays for high-throughput screening of engineered antibody and protein libraries.
  • Optimize assay performance by systematically evaluating biological and technical parameters to maximize robustness, sensitivity, reproducibility, and scalability.
  • Partner with microfluidics engineers to integrate biological assays into high-throughput microfluidic screening workflows.
  • Analyze and interpret experimental data to guide assay optimization, platform development, and scientific decision-making.
  • Troubleshoot biological and technical challenges, optimize established workflows, and identify opportunities to improve platform performance.
  • Document experimental workflows, communicate findings to cross-functional teams, and contribute to standard operating procedure development and continuous platform improvement.

Desired Qualifications

  • Experience co-expressing multiple cell-surface proteins.
  • Experience developing functional or cell-based assays for monoclonal antibody discovery.
  • Exposure to cell-free protein synthesis or related in-vitro expression systems.
  • Exposure to droplet microfluidics, single-cell screening, microfluidic sorting, or other high-throughput screening platforms.
  • Familiarity with next-generation sequencing-enabled antibody screening workflows.

About the Company

Ampersand

Modular therapeutics localized to diseased tissues

Ampersand Biomedicines develops modular therapeutics designed to act only in specific target tissues to improve efficacy and safety in disease treatment. Its products pair a localizing element that directs therapy to diseased tissues with an actuator that restores healthy biology, enabling precision medicine that reduces on-target, off-tissue toxicity. The company earns revenue through partnerships, licensing agreements, and potential direct sales of its therapeutics, working with pharmaceutical companies and healthcare providers. A key differentiator is its programmable, tissue-focused approach that combines disease-specific targeting with controllable therapeutic action, aiming to minimize side effects. The company’s goal is to advance its modular, tissue-localized platform and expand its therapeutic offerings through partnerships and funding, such as the $50 million investment from Flagship Pioneering.

Company size
51-200
Company stage
Series B
Total funding
$115M
Headquarters
Boston, MA
Founded
2020

Recently Posted Jobs

Explore more opportunities at Ampersand

See more jobs